Table 3.
Studies assessing the influence of iSUV of PET/CT in the localized gastric cancer setting
| Ref. | No of patients | Type of treatment | Findings |
|---|---|---|---|
| Stahl et al. (9) | 40 | Preoperative Chemotherapy | No significant correlation with prognosis |
| Vallböhmer et al. (23) | 42 | Preoperative Chemotherapy | No significant correlation with prognosis |
| Mochiki et al. (11) | 85 | Primary Surgery | High iSUV → Worse OS |
| Pak et al. (13) | 41 (with SRC histology) | Primary Surgery | High iSUV → Worse aggressive clinical course, although iSUV not independently prognostic |
| Lee JW et al. (12) | 271 (with subgroup analysis according to histopathologic subtypes) | Primary Surgery | High iSUV → Predictive factor for tumor recurrence for patients with TAC or PAC, not for SRC and MAC |
iSUV: Initial standardized uptake value; PET/CT: Positron emission tomography with computed tomography; OS: Overall survival; SRC: Signet ring cell; TAC: Tubular adenocarcinoma; PAC: Poorly differentiated adenocarcinoma; MAC: Mucinous adenocarcinoma.